Long-Term Results of Choledochoduodenostomy

por Neoptolemos, J. P., Radley, S.
Publicado 1992

Linking COVID-19 and Acute Pancreatitis Through the Pathogenic Effects of the SARS-CoV-2 S Protein Subunit 1 on Pancreatic Stellate Cells and Macrophages

por Neoptolemos, J P, Greenhalf, W
Publicado 2022

Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines.

por Stonelake, P. S., Jones, C. E., Neoptolemos, J. P., Baker, P. R.
Publicado 1997

Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease.

por Bramhall, S. R., Stamp, G. W., Dunn, J., Lemoine, N. R., Neoptolemos, J. P.
Publicado 1996

Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer

por Smith, R A, Tang, J, Tudur-Smith, C, Neoptolemos, J P, Ghaneh, P
Publicado 2011

Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses

por Sultana, A, Tudur Smith, C, Cunningham, D, Starling, N, Neoptolemos, J P, Ghaneh, P
Publicado 2008

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy

por Sultana, A, Tudur Smith, C, Cunningham, D, Starling, N, Tait, D, Neoptolemos, J P, Ghaneh, P
Publicado 2007

Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma

por Mann, Kulbir, Gilbert, T., Cicconi, S., Jackson, R., Whelan, P., Campbell, F., Halloran, C., Neoptolemos, J., Ghaneh, P.
Publicado 2019

Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.

por Phillips, S. M., Barton, C. M., Lee, S. J., Morton, D. G., Wallace, D. M., Lemoine, N. R., Neoptolemos, J. P.
Publicado 1994

Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer

por Dive, C, Smith, R A, Garner, E, Ward, T, George-Smith, S St, Campbell, F, Greenhalf, W, Ghaneh, P, Neoptolemos, J P
Publicado 2010

Reduced tumour growth of the human colonic cancer cell lines COLO-320 and HT-29 in vivo by dietary n-3 lipids.

por Sakaguchi, M., Rowley, S., Kane, N., Imray, C., Davies, A., Jones, C., Newbold, M., Keighley, M. R., Baker, P., Neoptolemos, J. P.
Publicado 1990

Impaired autophagy increases susceptibility to endotoxin-induced chronic pancreatitis

por Xia, L., Xu, Z., Zhou, X., Bergmann, F., Grabe, N., Büchler, M. W., Neoptolemos, J. P., Hackert, T., Kroemer, G., Fortunato, F.
Publicado 2020

A phase II trial of marimastat in advanced pancreatic cancer

por Evans, J D, Stark, A, Johnson, C D, Daniel, F, Carmichael, J, Buckels, J, Imrie, C W, Brown, P, Neoptolemos, J P
Publicado 2001

S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility

por Nedjadi, T, Kitteringham, N, Campbell, F, Jenkins, R E, Park, B K, Navarro, P, Ashcroft, F, Tepikin, A, Neoptolemos, J P, Costello, E
Publicado 2009

Dietary fat in relation to fatty acid composition of red cells and adipose tissue in colorectal cancer.

por Neoptolemos, J. P., Clayton, H., Heagerty, A. M., Nicholson, M. J., Johnson, B., Mason, J., Manson, K., James, R. F., Bell, P. R.
Publicado 1988

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer

por Stocken, D D, Büchler, M W, Dervenis, C, Bassi, C, Jeekel, H, Klinkenbijl, J H G, Bakkevold, K E, Takada, T, Amano, H, Neoptolemos, J P
Publicado 2005

Expression of human cationic trypsinogen (PRSS1) in murine acinar cells promotes pancreatitis and apoptotic cell death

por Athwal, T, Huang, W, Mukherjee, R, Latawiec, D, Chvanov, M, Clarke, R, Smith, K, Campbell, F, Merriman, C, Criddle, D, Sutton, R, Neoptolemos, J, Vlatković, N
Publicado 2014

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

por Barton, C. M., Staddon, S. L., Hughes, C. M., Hall, P. A., O'Sullivan, C., Klöppel, G., Theis, B., Russell, R. C., Neoptolemos, J., Williamson, R. C.
Publicado 1991

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

por Neoptolemos, J P, Stocken, D D, Tudur Smith, C, Bassi, C, Ghaneh, P, Owen, E, Moore, M, Padbury, R, Doi, R, Smith, D, Büchler, M W
Publicado 2009

iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance

por Tonack, S, Jenkinson, C, Cox, T, Elliott, V, Jenkins, R E, Kitteringham, N R, Greenhalf, W, Shaw, V, Michalski, C W, Friess, H, Neoptolemos, J P, Costello, E
Publicado 2013